# Adaptive Biotechnologies Corporation

Canonical: https://abierto.us/vendors/adaptive-biotechnologies-corporation-dmw5bnq331k9

- UEI: DMW5BNQ331K9
- CAGE: 5SRQ2
- Location: Seattle, WA
- Awards in window: 3 (4 transactions), $18,975 obligated, July 16, 2026 to September 1, 2026

## Awarding agencies

- Department of Veterans Affairs: 2 awards, $19,500
- National Institutes of Health: 1 awards, -$525

## Industries

- 621511 Medical Laboratories: $19,500
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0
- 541380 Testing Laboratories and Services: -$525

## Competition

- Competed Under SAP: 2 awards
- Not Competed Under SAP: 1 awards

## Solicitations won

- Reference Laboratory MRD Testing PDX (36C26026Q0851). https://abierto.us/opportunities/36c26026q0851

## Largest awards

- 36C26026P0708 (purchase order): $19,500, 260-Network Contract Office 20. Reference Lab Testing Portland Oregon. https://www.usaspending.gov/award/CONT_AWD_36C26026P0708_3600_-NONE-_-NONE-/
- 36C24126N0614 (bpa call): $0, 241-Network Contract Office 01. Clonoseq Testing for Boston and West Haven VA HCS. https://www.usaspending.gov/award/CONT_AWD_36C24126N0614_3600_36C24122A0124_3600/
- 75N93021P01430 (purchase order): -$525, National Institutes of Health Niaid. To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N93021P01430_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/adaptive-biotechnologies-corporation-dmw5bnq331k9.